Hikma Pharmaceuticals Governance Journey
The case begins with Said Darwazah, president and CEO of Hikma Pharmaceuticals, the multinational generics company, anticipating the company’s annual general meeting in 2017 and considering changes made the previous year to address the concerns of proxy advisors and some shareholders on Hikma’s dependence on a joint chairman. / CEO position, the long tenure of …